nodes	percent_of_prediction	percent_of_DWPC	metapath
Atorvastatin—UGT2B7—urinary bladder cancer	0.428	1	CbGaD
Atorvastatin—ABCC5—Fluorouracil—urinary bladder cancer	0.0491	0.112	CbGbCtD
Atorvastatin—ABCC5—Cisplatin—urinary bladder cancer	0.0417	0.0953	CbGbCtD
Atorvastatin—UGT2B7—Epirubicin—urinary bladder cancer	0.0286	0.0653	CbGbCtD
Atorvastatin—CYP2B6—Thiotepa—urinary bladder cancer	0.0275	0.0627	CbGbCtD
Atorvastatin—ABCC4—Fluorouracil—urinary bladder cancer	0.0236	0.0539	CbGbCtD
Atorvastatin—ABCC1—Epirubicin—urinary bladder cancer	0.0203	0.0464	CbGbCtD
Atorvastatin—UGT1A1—Etoposide—urinary bladder cancer	0.0192	0.044	CbGbCtD
Atorvastatin—ABCB1—Mitomycin—urinary bladder cancer	0.0186	0.0424	CbGbCtD
Atorvastatin—ABCC1—Etoposide—urinary bladder cancer	0.0158	0.0361	CbGbCtD
Atorvastatin—SLCO1B3—Methotrexate—urinary bladder cancer	0.0151	0.0345	CbGbCtD
Atorvastatin—ABCC2—Carboplatin—urinary bladder cancer	0.0139	0.0319	CbGbCtD
Atorvastatin—ABCC4—Methotrexate—urinary bladder cancer	0.013	0.0297	CbGbCtD
Atorvastatin—ABCC2—Cisplatin—urinary bladder cancer	0.0119	0.0272	CbGbCtD
Atorvastatin—ABCC2—Etoposide—urinary bladder cancer	0.0117	0.0268	CbGbCtD
Atorvastatin—ABCC1—Doxorubicin—urinary bladder cancer	0.0108	0.0246	CbGbCtD
Atorvastatin—ABCC1—Methotrexate—urinary bladder cancer	0.0105	0.0239	CbGbCtD
Atorvastatin—SLCO1A2—Methotrexate—urinary bladder cancer	0.00933	0.0213	CbGbCtD
Atorvastatin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0088	0.0201	CbGbCtD
Atorvastatin—CYP3A4—Thiotepa—urinary bladder cancer	0.00843	0.0193	CbGbCtD
Atorvastatin—ABCC2—Doxorubicin—urinary bladder cancer	0.00799	0.0182	CbGbCtD
Atorvastatin—ABCC2—Methotrexate—urinary bladder cancer	0.00774	0.0177	CbGbCtD
Atorvastatin—CYP2B6—Cisplatin—urinary bladder cancer	0.00758	0.0173	CbGbCtD
Atorvastatin—CYP2C8—Fluorouracil—urinary bladder cancer	0.00676	0.0154	CbGbCtD
Atorvastatin—CYP3A5—Etoposide—urinary bladder cancer	0.00586	0.0134	CbGbCtD
Atorvastatin—CYP2C8—Etoposide—urinary bladder cancer	0.00564	0.0129	CbGbCtD
Atorvastatin—ABCB1—Gemcitabine—urinary bladder cancer	0.00535	0.0122	CbGbCtD
Atorvastatin—CYP2B6—Doxorubicin—urinary bladder cancer	0.00508	0.0116	CbGbCtD
Atorvastatin—CYP2C9—Fluorouracil—urinary bladder cancer	0.00471	0.0108	CbGbCtD
Atorvastatin—CYP2C9—Cisplatin—urinary bladder cancer	0.004	0.00915	CbGbCtD
Atorvastatin—ABCB1—Cisplatin—urinary bladder cancer	0.00388	0.00888	CbGbCtD
Atorvastatin—ABCB1—Etoposide—urinary bladder cancer	0.00382	0.00872	CbGbCtD
Atorvastatin—UGT1A1—urine—urinary bladder cancer	0.00299	0.0644	CbGeAlD
Atorvastatin—ABCB1—Doxorubicin—urinary bladder cancer	0.0026	0.00595	CbGbCtD
Atorvastatin—ABCB1—Methotrexate—urinary bladder cancer	0.00252	0.00576	CbGbCtD
Atorvastatin—CYP2D6—Doxorubicin—urinary bladder cancer	0.00245	0.0056	CbGbCtD
Atorvastatin—CYP3A4—Etoposide—urinary bladder cancer	0.00229	0.00522	CbGbCtD
Atorvastatin—Pitavastatin—UGT2B7—urinary bladder cancer	0.00198	0.519	CrCbGaD
Atorvastatin—Fluvastatin—UGT2B7—urinary bladder cancer	0.00184	0.481	CrCbGaD
Atorvastatin—CYP2C19—urine—urinary bladder cancer	0.00162	0.0349	CbGeAlD
Atorvastatin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00156	0.00356	CbGbCtD
Atorvastatin—AHR—prostate gland—urinary bladder cancer	0.00127	0.0274	CbGeAlD
Atorvastatin—UGT2B7—prostate gland—urinary bladder cancer	0.00126	0.0272	CbGeAlD
Atorvastatin—CYP2C9—urine—urinary bladder cancer	0.00126	0.0271	CbGeAlD
Atorvastatin—AHR—seminal vesicle—urinary bladder cancer	0.00108	0.0232	CbGeAlD
Atorvastatin—UGT1A1—prostate gland—urinary bladder cancer	0.00107	0.0231	CbGeAlD
Atorvastatin—DPP4—prostate gland—urinary bladder cancer	0.00105	0.0227	CbGeAlD
Atorvastatin—ABCC5—prostate gland—urinary bladder cancer	0.00101	0.0217	CbGeAlD
Atorvastatin—CYP3A4—urine—urinary bladder cancer	0.000957	0.0206	CbGeAlD
Atorvastatin—CYP2D6—urine—urinary bladder cancer	0.000942	0.0203	CbGeAlD
Atorvastatin—HMGCR—prostate gland—urinary bladder cancer	0.000931	0.0201	CbGeAlD
Atorvastatin—AHR—smooth muscle tissue—urinary bladder cancer	0.000901	0.0194	CbGeAlD
Atorvastatin—DPP4—seminal vesicle—urinary bladder cancer	0.000891	0.0192	CbGeAlD
Atorvastatin—UGT2B7—renal system—urinary bladder cancer	0.00086	0.0185	CbGeAlD
Atorvastatin—AHR—urethra—urinary bladder cancer	0.000852	0.0184	CbGeAlD
Atorvastatin—SLCO2B1—prostate gland—urinary bladder cancer	0.000789	0.017	CbGeAlD
Atorvastatin—HMGCR—seminal vesicle—urinary bladder cancer	0.000788	0.017	CbGeAlD
Atorvastatin—DPP4—epithelium—urinary bladder cancer	0.000774	0.0167	CbGeAlD
Atorvastatin—SLCO1B3—vagina—urinary bladder cancer	0.000762	0.0164	CbGeAlD
Atorvastatin—DPP4—smooth muscle tissue—urinary bladder cancer	0.000746	0.0161	CbGeAlD
Atorvastatin—UGT1A1—renal system—urinary bladder cancer	0.000731	0.0158	CbGeAlD
Atorvastatin—DPP4—renal system—urinary bladder cancer	0.000718	0.0155	CbGeAlD
Atorvastatin—ABCC4—prostate gland—urinary bladder cancer	0.000699	0.0151	CbGeAlD
Atorvastatin—AHR—female reproductive system—urinary bladder cancer	0.000694	0.015	CbGeAlD
Atorvastatin—UGT2B7—female reproductive system—urinary bladder cancer	0.000688	0.0148	CbGeAlD
Atorvastatin—HMGCR—epithelium—urinary bladder cancer	0.000684	0.0148	CbGeAlD
Atorvastatin—ABCC2—prostate gland—urinary bladder cancer	0.000677	0.0146	CbGeAlD
Atorvastatin—HMGCR—smooth muscle tissue—urinary bladder cancer	0.00066	0.0142	CbGeAlD
Atorvastatin—HMGCR—renal system—urinary bladder cancer	0.000635	0.0137	CbGeAlD
Atorvastatin—AHR—vagina—urinary bladder cancer	0.000628	0.0135	CbGeAlD
Atorvastatin—HMGCR—urethra—urinary bladder cancer	0.000624	0.0134	CbGeAlD
Atorvastatin—SLCO1B1—renal system—urinary bladder cancer	0.000608	0.0131	CbGeAlD
Atorvastatin—ABCC1—prostate gland—urinary bladder cancer	0.000596	0.0128	CbGeAlD
Atorvastatin—DPP4—female reproductive system—urinary bladder cancer	0.000575	0.0124	CbGeAlD
Atorvastatin—SLCO2B1—renal system—urinary bladder cancer	0.000538	0.0116	CbGeAlD
Atorvastatin—DPP4—vagina—urinary bladder cancer	0.00052	0.0112	CbGeAlD
Atorvastatin—HMGCR—female reproductive system—urinary bladder cancer	0.000508	0.011	CbGeAlD
Atorvastatin—ABCC1—seminal vesicle—urinary bladder cancer	0.000504	0.0109	CbGeAlD
Atorvastatin—ABCC5—vagina—urinary bladder cancer	0.000498	0.0107	CbGeAlD
Atorvastatin—SLCO1A2—renal system—urinary bladder cancer	0.000495	0.0107	CbGeAlD
Atorvastatin—SLCO1B1—female reproductive system—urinary bladder cancer	0.000487	0.0105	CbGeAlD
Atorvastatin—ABCC4—renal system—urinary bladder cancer	0.000476	0.0103	CbGeAlD
Atorvastatin—ABCC2—renal system—urinary bladder cancer	0.000461	0.00994	CbGeAlD
Atorvastatin—HMGCR—vagina—urinary bladder cancer	0.00046	0.00991	CbGeAlD
Atorvastatin—CYP3A5—prostate gland—urinary bladder cancer	0.000458	0.00987	CbGeAlD
Atorvastatin—SLCO2B1—female reproductive system—urinary bladder cancer	0.000431	0.00929	CbGeAlD
Atorvastatin—AHR—lymph node—urinary bladder cancer	0.000406	0.00875	CbGeAlD
Atorvastatin—ABCC1—urethra—urinary bladder cancer	0.000399	0.0086	CbGeAlD
Atorvastatin—ABCC4—female reproductive system—urinary bladder cancer	0.000381	0.00822	CbGeAlD
Atorvastatin—ABCC2—female reproductive system—urinary bladder cancer	0.000369	0.00796	CbGeAlD
Atorvastatin—CYP2C8—renal system—urinary bladder cancer	0.000346	0.00745	CbGeAlD
Atorvastatin—DPP4—lymph node—urinary bladder cancer	0.000337	0.00725	CbGeAlD
Atorvastatin—ABCC5—lymph node—urinary bladder cancer	0.000322	0.00694	CbGeAlD
Atorvastatin—CYP3A5—renal system—urinary bladder cancer	0.000312	0.00673	CbGeAlD
Atorvastatin—CYP2B6—renal system—urinary bladder cancer	0.00031	0.00669	CbGeAlD
Atorvastatin—HMGCR—lymph node—urinary bladder cancer	0.000297	0.00641	CbGeAlD
Atorvastatin—ABCC1—vagina—urinary bladder cancer	0.000294	0.00634	CbGeAlD
Atorvastatin—CYP2C19—vagina—urinary bladder cancer	0.000287	0.00619	CbGeAlD
Atorvastatin—CYP2C8—female reproductive system—urinary bladder cancer	0.000277	0.00597	CbGeAlD
Atorvastatin—SLCO2B1—lymph node—urinary bladder cancer	0.000252	0.00543	CbGeAlD
Atorvastatin—CYP2C8—vagina—urinary bladder cancer	0.00025	0.0054	CbGeAlD
Atorvastatin—CYP2B6—female reproductive system—urinary bladder cancer	0.000248	0.00536	CbGeAlD
Atorvastatin—CYP2C9—female reproductive system—urinary bladder cancer	0.000246	0.0053	CbGeAlD
Atorvastatin—ABCB1—prostate gland—urinary bladder cancer	0.000243	0.00524	CbGeAlD
Atorvastatin—CYP3A4—renal system—urinary bladder cancer	0.000234	0.00505	CbGeAlD
Atorvastatin—CYP2D6—renal system—urinary bladder cancer	0.000231	0.00497	CbGeAlD
Atorvastatin—CYP3A5—vagina—urinary bladder cancer	0.000226	0.00487	CbGeAlD
Atorvastatin—CYP2B6—vagina—urinary bladder cancer	0.000225	0.00484	CbGeAlD
Atorvastatin—ABCC4—lymph node—urinary bladder cancer	0.000223	0.00481	CbGeAlD
Atorvastatin—ABCC2—lymph node—urinary bladder cancer	0.000216	0.00466	CbGeAlD
Atorvastatin—ABCB1—seminal vesicle—urinary bladder cancer	0.000206	0.00444	CbGeAlD
Atorvastatin—ABCC1—lymph node—urinary bladder cancer	0.00019	0.0041	CbGeAlD
Atorvastatin—CYP3A4—female reproductive system—urinary bladder cancer	0.000188	0.00404	CbGeAlD
Atorvastatin—CYP2D6—female reproductive system—urinary bladder cancer	0.000185	0.00398	CbGeAlD
Atorvastatin—ABCB1—epithelium—urinary bladder cancer	0.000179	0.00385	CbGeAlD
Atorvastatin—ABCB1—renal system—urinary bladder cancer	0.000166	0.00357	CbGeAlD
Atorvastatin—ABCB1—urethra—urinary bladder cancer	0.000163	0.00351	CbGeAlD
Atorvastatin—ABCB1—female reproductive system—urinary bladder cancer	0.000133	0.00286	CbGeAlD
Atorvastatin—ABCB1—vagina—urinary bladder cancer	0.00012	0.00259	CbGeAlD
Atorvastatin—ABCB1—lymph node—urinary bladder cancer	7.77e-05	0.00167	CbGeAlD
Atorvastatin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	6.88e-06	8.22e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—TYMS—urinary bladder cancer	6.87e-06	8.21e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	6.82e-06	8.14e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.8e-06	8.12e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—GSTM1—urinary bladder cancer	6.79e-06	8.11e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—NCOR1—urinary bladder cancer	6.79e-06	8.11e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.78e-06	8.1e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	6.76e-06	8.07e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—GPX1—urinary bladder cancer	6.75e-06	8.06e-05	CbGpPWpGaD
Atorvastatin—ABCC4—Hemostasis—TP53—urinary bladder cancer	6.74e-06	8.06e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.73e-06	8.04e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	6.72e-06	8.03e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	6.7e-06	8.01e-05	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	6.67e-06	7.97e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—PTGS2—urinary bladder cancer	6.63e-06	7.92e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	6.62e-06	7.91e-05	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	6.61e-06	7.9e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.61e-06	7.9e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—EP300—urinary bladder cancer	6.58e-06	7.86e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.56e-06	7.84e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—FGFR3—urinary bladder cancer	6.56e-06	7.84e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—NAT2—urinary bladder cancer	6.54e-06	7.82e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	6.53e-06	7.8e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—GPX1—urinary bladder cancer	6.5e-06	7.77e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.49e-06	7.75e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	6.48e-06	7.74e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	6.45e-06	7.71e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	6.45e-06	7.71e-05	CbGpPWpGaD
Atorvastatin—ABCC4—Hemostasis—HRAS—urinary bladder cancer	6.45e-06	7.71e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	6.45e-06	7.7e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—SRC—urinary bladder cancer	6.4e-06	7.65e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—ERCC2—urinary bladder cancer	6.39e-06	7.63e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	6.23e-06	7.44e-05	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—PPARG—urinary bladder cancer	6.21e-06	7.42e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	6.18e-06	7.38e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	6.17e-06	7.37e-05	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—PTEN—urinary bladder cancer	6.15e-06	7.35e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	6.11e-06	7.3e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	6.07e-06	7.25e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	6.06e-06	7.24e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	6e-06	7.17e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	6e-06	7.17e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—MTHFR—urinary bladder cancer	6e-06	7.17e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	5.99e-06	7.16e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.97e-06	7.13e-05	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	5.97e-06	7.13e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	5.92e-06	7.08e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	5.92e-06	7.08e-05	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—EP300—urinary bladder cancer	5.86e-06	7e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.83e-06	6.97e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	5.82e-06	6.96e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	5.79e-06	6.91e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—PTEN—urinary bladder cancer	5.78e-06	6.91e-05	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	5.75e-06	6.87e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—MYC—urinary bladder cancer	5.74e-06	6.85e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.73e-06	6.85e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.72e-06	6.83e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	5.72e-06	6.83e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	5.7e-06	6.81e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	5.67e-06	6.78e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—RRM2—urinary bladder cancer	5.65e-06	6.75e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—EGFR—urinary bladder cancer	5.61e-06	6.7e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	5.59e-06	6.67e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—CREBBP—urinary bladder cancer	5.58e-06	6.67e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.58e-06	6.66e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	5.57e-06	6.65e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—EP300—urinary bladder cancer	5.51e-06	6.59e-05	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	5.42e-06	6.47e-05	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	5.41e-06	6.46e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	5.36e-06	6.4e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	5.36e-06	6.4e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.33e-06	6.36e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	5.32e-06	6.36e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—KRAS—urinary bladder cancer	5.3e-06	6.33e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	5.28e-06	6.3e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	5.24e-06	6.25e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—ENO2—urinary bladder cancer	5.23e-06	6.25e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	5.23e-06	6.25e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	5.2e-06	6.21e-05	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	5.2e-06	6.21e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.12e-06	6.11e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	5.07e-06	6.06e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—RHOA—urinary bladder cancer	5.05e-06	6.03e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—PPARG—urinary bladder cancer	5.05e-06	6.03e-05	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—PTEN—urinary bladder cancer	5.01e-06	5.99e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.93e-06	5.89e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.93e-06	5.89e-05	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	4.89e-06	5.84e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.89e-06	5.84e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.89e-06	5.84e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—PPARG—urinary bladder cancer	4.87e-06	5.82e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.86e-06	5.8e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	4.85e-06	5.79e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	4.84e-06	5.78e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.78e-06	5.71e-05	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—EP300—urinary bladder cancer	4.78e-06	5.71e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	4.77e-06	5.7e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.75e-06	5.67e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	4.74e-06	5.66e-05	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	4.72e-06	5.64e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.7e-06	5.61e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—CREBBP—urinary bladder cancer	4.68e-06	5.59e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—ERBB2—urinary bladder cancer	4.68e-06	5.59e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.67e-06	5.57e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	4.66e-06	5.57e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	4.63e-06	5.53e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—PTGS2—urinary bladder cancer	4.57e-06	5.46e-05	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—HRAS—urinary bladder cancer	4.51e-06	5.38e-05	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—EP300—urinary bladder cancer	4.5e-06	5.38e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.46e-06	5.32e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	4.44e-06	5.31e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	4.43e-06	5.29e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	4.38e-06	5.23e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	4.38e-06	5.23e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.33e-06	5.18e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	4.32e-06	5.16e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.28e-06	5.12e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.28e-06	5.12e-05	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—PTEN—urinary bladder cancer	4.26e-06	5.09e-05	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	4.26e-06	5.08e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	4.25e-06	5.07e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—NQO1—urinary bladder cancer	4.22e-06	5.04e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	4.2e-06	5.01e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.19e-06	5.01e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	4.12e-06	4.92e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.1e-06	4.9e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.09e-06	4.89e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	4.08e-06	4.87e-05	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—EP300—urinary bladder cancer	4.06e-06	4.86e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	4.04e-06	4.82e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.03e-06	4.82e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.03e-06	4.81e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—CDKN1A—urinary bladder cancer	4e-06	4.77e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—PTEN—urinary bladder cancer	3.99e-06	4.76e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.97e-06	4.75e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	3.97e-06	4.74e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.94e-06	4.71e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.9e-06	4.67e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	3.87e-06	4.63e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—PTGS2—urinary bladder cancer	3.83e-06	4.57e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.82e-06	4.57e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—EP300—urinary bladder cancer	3.8e-06	4.54e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	3.78e-06	4.52e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	3.75e-06	4.48e-05	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	3.71e-06	4.43e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	3.71e-06	4.43e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	3.71e-06	4.43e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—SRC—urinary bladder cancer	3.7e-06	4.42e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.65e-06	4.37e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	3.64e-06	4.35e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.6e-06	4.3e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.55e-06	4.24e-05	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—EP300—urinary bladder cancer	3.54e-06	4.23e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.52e-06	4.2e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	3.49e-06	4.17e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.49e-06	4.16e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.48e-06	4.16e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—PTEN—urinary bladder cancer	3.46e-06	4.14e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.35e-06	4e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	3.34e-06	3.99e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—PTEN—urinary bladder cancer	3.34e-06	3.99e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.33e-06	3.98e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—MYC—urinary bladder cancer	3.31e-06	3.96e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.31e-06	3.96e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.31e-06	3.96e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.31e-06	3.96e-05	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—EP300—urinary bladder cancer	3.3e-06	3.95e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	3.28e-06	3.92e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	3.28e-06	3.92e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—TYMS—urinary bladder cancer	3.27e-06	3.91e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—EGFR—urinary bladder cancer	3.24e-06	3.87e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	3.23e-06	3.86e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	3.23e-06	3.86e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.22e-06	3.85e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.22e-06	3.85e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—EP300—urinary bladder cancer	3.18e-06	3.8e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.18e-06	3.8e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	3.17e-06	3.79e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	3.17e-06	3.79e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	3.14e-06	3.75e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.13e-06	3.73e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	3.11e-06	3.72e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.09e-06	3.7e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.08e-06	3.68e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.07e-06	3.67e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—KRAS—urinary bladder cancer	3.06e-06	3.66e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.05e-06	3.65e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.04e-06	3.64e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.04e-06	3.64e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.04e-06	3.63e-05	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	3.03e-06	3.62e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.02e-06	3.61e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.02e-06	3.61e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	3.02e-06	3.6e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.95e-06	3.52e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.93e-06	3.5e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.92e-06	3.48e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.91e-06	3.48e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.89e-06	3.45e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.86e-06	3.42e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.86e-06	3.41e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.84e-06	3.39e-05	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.78e-06	3.32e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.69e-06	3.21e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.67e-06	3.19e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.66e-06	3.18e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—HRAS—urinary bladder cancer	2.6e-06	3.11e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.6e-06	3.1e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.55e-06	3.05e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	2.47e-06	2.95e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.41e-06	2.88e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.37e-06	2.83e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.32e-06	2.77e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.28e-06	2.72e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.22e-06	2.66e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.18e-06	2.61e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.17e-06	2.59e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.16e-06	2.58e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	2.15e-06	2.57e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.11e-06	2.52e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.1e-06	2.5e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.09e-06	2.5e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.08e-06	2.48e-05	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—EP300—urinary bladder cancer	2.05e-06	2.45e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.01e-06	2.41e-05	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.01e-06	2.4e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.99e-06	2.38e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.99e-06	2.38e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.91e-06	2.28e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.87e-06	2.24e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.87e-06	2.23e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.82e-06	2.18e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.82e-06	2.18e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.76e-06	2.1e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.74e-06	2.08e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.72e-06	2.05e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.7e-06	2.03e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.63e-06	1.94e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.59e-06	1.9e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.55e-06	1.85e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—EP300—urinary bladder cancer	1.52e-06	1.81e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.5e-06	1.79e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.48e-06	1.77e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.43e-06	1.71e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.43e-06	1.7e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.42e-06	1.69e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.37e-06	1.64e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.12e-06	1.34e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.79e-07	1.17e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—EP300—urinary bladder cancer	9.33e-07	1.12e-05	CbGpPWpGaD
